Post Profile

Morphosys moves closer to getting first antibody drug on market

FRANKFURT (Reuters) - German biotech Morphosys moved a step closer to getting its first antibody drug onto the market as its licensee, Johnson & Johnson unit Jenssen, reported positive results from a phase 3 study of psoriasis drug guselkumab.
read more


Related Posts

Crucell Announces Positive Results Of Phase II Rabies Monoclonal Antibody Combination Clinical Study In Philippines

Health : Medical News Today

Dutch biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL) (SWISS: CRX) today announced the results of a second phase II clinical study of its investigational rabies monoclonal antibody combination, which started in May 2...

PROLOR Biotech Reports Positive Preclinical Results In Weight Loss Study Of Its Long-Acting Anti-Obesity Drug Candidate

Health : Medical News Today

PROLOR Biotech, Inc. (NYSE Amex: PBTH) reported positive results from a comparative animal study of its long-acting anti-obesity drug candidate oxyntomodulin (OXY-RPEG). The study measured the potential therapeutic effect of OXY-RPE...

Psoriasis drug shows promise in diabetes trial

Health : Medical News Today

A drug previously used to treat psoriasis has shown positive results in a phase II trial assessing its effectiveness at treating type 1 diabetes, according to a study published in The Lancet Diabetes and Endocrinology. The drug, ale...

PROLOR Biotech Reports Positive Top-Line Results From Phase I Study Of Its Longer-Acting Version Of Human Growth Hormone

Health : Medical News Today

PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) reported positive top-line results from a Phase I study of its longer-acting version of human growth hormone (hGH). The study was designed to measure the potential durability (half-li...

J&J psoriasis drug tops placebo, Humira in late stage study

Health : Reuters: Health

(Reuters) - An experimental biotech drug developed by Johnson & Johnson proved more effective at clearing moderate to severe cases of the skin condition plaque psoriasis than a placebo or Abbvie Inc's big-selling Humira, according t...


Copyright © 2016 Regator, LLC